Bottom line
VHT vs PPH: the short answer
VHT (Vanguard Health Care Index Fund) and PPH (VanEck Pharmaceutical ETF) share a meaningful slice of their top holdings — about 43% by weight.
But VHT is far broader, holding 407 positions to 26 for PPH, so beyond the top names it adds exposure PPH doesn't have.
VHT is cheaper at 0.09% vs 0.36% — a difference of $27 a year per $10,000 invested.
Over five years, PPH returned +11.3% a year vs +7.2% for VHT (reporting dates differ).
Updated Nov 19, 2026
VHT vs PPH side by side
| VHT | PPH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Vanguard | VanEck |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 0.36% |
| Annual cost per $10k | $9 | $36 |
| 10-yr cost on $10k (prospectus) | $115 | $456 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +2.7% | +21.9% |
| 5-yr return (annualized) | +7.2% | +11.3% |
| 10-yr return (annualized) | +8.8% | +6.7% |
| Best quarter | +16.5% | +16.5% |
| Worst quarter | −13.1% | −15.0% |
| Net assets (fund) | $19.0B | $879.5M |
| Number of holdings | 407 | 26 |
| Portfolio turnover | 4% | 3% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VHT | PPH | Difference |
|---|---|---|---|
| 2024 | +2.7% | +8.1% | −5.5% |
| 2023 | +2.5% | +6.9% | −4.4% |
| 2022 | −5.5% | +2.6% | −8.2% |
| 2021 | +20.5% | +18.3% | +2.2% |
| 2020 | +18.2% | +5.2% | +13.0% |
| 2019 | +22.0% | +19.1% | +2.8% |
| 2018 | +5.6% | −5.7% | +11.2% |
| 2017 | +23.3% | +15.4% | +7.9% |
| 2016 | −3.3% | −17.8% | +14.4% |
Source: Fund prospectus bar charts
Holdings overlap
8 of VHT's top 25 holdings also appear in PPH's top 25.
| Holding | VHT | PPH |
|---|---|---|
| Eli Lilly & Co | 14.04% | 20.23% |
| Johnson & Johnson | 8.47% | 4.35% |
| AbbVie Inc | 6.09% | 4.57% |
| Merck & Co Inc | 4.66% | 9.85% |
| Pfizer Inc | 2.35% | 4.51% |
| Bristol-Myers Squibb Co | 1.84% | 4.47% |
| McKesson Corp | 1.45% | 4.12% |
| Cencora Inc | 0.79% | 3.36% |
Source: SEC Form N-PORT
VHT top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
PPH top 10
- Eli Lilly & Co — 20.23%
- Novartis AG — 10.63%
- Merck & Co Inc — 9.85%
- Novo Nordisk A/S — 5.37%
- AbbVie Inc — 4.57%
- Pfizer Inc — 4.51%
- Bristol-Myers Squibb Co — 4.47%
- Gsk Plc — 4.42%
- Johnson & Johnson — 4.35%
- AstraZeneca PLC — 4.33%
FAQ
What is the difference between VHT and PPH?
Which is cheaper, VHT or PPH?
Should I own both VHT and PPH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.